Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

Mon, 12th Feb 2024 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

Stifel cuts AstraZeneca price target to 12,000 (12,550) pence - 'buy'

----------

Barclays cuts AstraZeneca price target to 12,500 (13,500) pence - 'overweight'

----------

UBS cuts AstraZeneca price target to 9,900 (10,700) pence - 'sell'

----------

Deutsche Bank cuts Legal & General price target to 300 (305) pence - 'buy'

----------

RBC cuts JD Sports price target to 135 (150) pence - 'outperform'

----------

Barclays raises Diploma price target to 3,800 (3,400) pence - 'overweight'

----------

Goldman Sachs raises BAT price target to 2,750 (2,700) pence - 'neutral'

----------

JPMorgan cuts BAT price target to 2,550 (2,700) pence - 'neutral'

----------

Berenberg raises Compass price target to 2,460 (2,430) pence - 'buy'

----------

DZ Bank cuts fair value for Anglo American to 1,550 (1,600) pence - sell

----------

JPMorgan cuts Anglo American price target to 2,350 (2,450) pence - 'overweight'

----------

FTSE 250

----------

JPMorgan cuts Ashmore price target to 184 (185) pence - 'underweight'

----------

SMALL CAP AND OTHER MAIN MARKET

----------

Deutsche Bank raises Just Eat Takeaway price target to 23 (22) EUR - 'buy'

----------

Deutsche Bank starts Deliveroo with 'buy' - price target 180 pence

----------

Jefferies raises Greencore price target to 100 (90) pence - 'hold'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.